Hang Ling

Chang Gung University

H指数:10

被引数:357

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Triplet radio-chemo-immunotherapy reprograms the PD-L1-CDK6 axis to remodel the tumor microenvironment and overcome immune resistance in head and neck cancer

三联放射-化学-免疫疗法重编程PD-L1-CDK6轴以重塑肿瘤微环境并克服头颈癌的免疫抵抗

European Journal of Pharmaceutical Sciences

IF4.7

2026-08-010

OAAI

Deep learning radiomics based on multimodal MRI for preoperative prediction of N stage in tongue squamous cell carcinoma: a multicenter study

基于多模态MRI的深度学习放射组学用于舌鳞状细胞癌术前N分期的预测：一项多中心研究

BMC Oral Health

IF3.1

2026-03-300

OAAI

RHOJ-induced chemotherapy resistance through epithelial–mesenchymal transition in drug-tolerant persister cells of head and neck cancer

Translational Oncology

IF4.1

2026-01-170

OAAI

Redox-Driven FABP1/PPARγ Signaling Fuels Peroxisomal Fatty Acid Oxidation and Confers Cetuximab Resistance in Drug-Tolerant Head and Neck Cancer Cells

氧化还原驱动的FABP1/PPARγ信号通路促进过氧化物酶体脂肪酸氧化，并赋予耐药性头颈癌细胞西妥昔耐药性。

Free Radical Biology and Medicine

IF8.2

2026-01-120

PRE

Targeting the DKK1/CSF1 Signaling Axis to Reprogram M2 Macrophages and Reverse Chemoresistance in Head and Neck Squamous Cell Carcinoma

靶向DKK1/CSF1信号轴以重编程M2巨噬细胞并逆转头颈部鳞状细胞癌的化疗耐药性

European Journal of Pharmaceutical Sciences

IF4.7

2026-01-110

OAAI

Long-Term Anticoagulation and Outcomes of Head and Neck Cancer: Analysis of the US Nationwide Inpatient Sample

长期抗凝治疗与头颈癌的结局：美国全国住院样本分析

Clinical and Experimental Pharmacology and Physiology

IF2.5

2025-11-070

PRE

Drug-tolerant persister cells in head and neck squamous cell carcinoma: Molecular mechanisms and therapeutic opportunities

头颈鳞状细胞癌中的耐药持久性细胞：分子机制和治疗机会

Translational Oncology

IF4.1

2025-10-290

OAAI

MRI-based deep learning radiomics in predicting histological differentiation of oropharyngeal cancer: a multicenter cohort study

基于MRI的深度学习放射组学在预测口咽癌组织学分化中的应用：一项多中心队列研究

clinical translational oncology

IF0

2025-09-030

PRE

Presence of lymph nodes and metastasis within prostatic anterior fat pad in radical prostatectomy patients: A single Chinese institution experience and literature review

EJSO

IF2.9

2023-12-010

OAAI

Bicarbonate transporter SLC4A7 promotes EMT and metastasis of HNSCC by activating the PI3K/AKT/mTOR signaling pathway

MOLECULAR CARCINOGENESIS

IF3.2

2023-02-0210

PRE

MRI-based radiomics analysis for preoperative evaluation of lymph node metastasis in hypopharyngeal squamous cell carcinoma

基于MRI的影像组学分析对下咽鳞癌淋巴结转移的术前评估

FRONTIERS IN ONCOLOGY

IF3.3

2022-09-237

OAAI

Pretreatment Glasgow Prognostic Score Correlated with Serum Histidine Level and Three-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma and Optimal Performance Status

NUTRIENTS

IF5

2022-08-244

OAAI

Inflammation Status and Body Composition Predict Two-Year Mortality of Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma under Provision of Recommended Energy Intake during Concurrent Chemoradiotherapy

BIOMEDICINES

IF3.9

2022-02-065

OAAI

Comprehensive analysis of PPPCs family reveals the clinical significance of PPP1CA and PPP4C in breast cancer

BIOENGINEERED

IF4.2

2021-12-2919

OAAI

Concurrent Chemoradiotherapy Induces Body Composition Changes in Locally Advanced Head and Neck Squamous Cell Carcinoma: Comparison between Oral Cavity and Non-Oral Cavity Cancer

NUTRIENTS

IF5

2021-08-265

OAAI

Comorbidity, Radiation Duration, and Pretreatment Body Muscle Mass Predict Early Treatment Failure in Taiwanese Patients with Locally Advanced Oral Cavity Squamous Cell Carcinoma after Completion of Adjuvant Concurrent Chemoradiotherapy

DIAGNOSTICS

IF3.3

2021-07-021

OAAI

Comprehensive Analysis of Myeloid Signature Genes in Head and Neck Squamous Cell Carcinoma to Predict the Prognosis and Immune Infiltration

头颈部鳞状细胞癌髓系标记基因综合分析预测预后及免疫浸润

FRONTIERS IN IMMUNOLOGY

IF5.9

2021-04-2915

OAAI

Role of the Appendicular Skeletal Muscle Index for Predicting the Recurrence-Free Survival of Head and Neck Cancer

DIAGNOSTICS

IF3.3

2021-02-147

OAAI

miR-3187-3p enhances migration and invasion by targeting PER2 in head and neck squamous cell carcinomas

JOURNAL OF CANCER

IF3.2

2021-01-0112

OAAI

Determining Malnutrition Assessment Criteria to Predict One-Year Mortality for Locally Advanced Head and Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy

NUTRIENTS

IF5

2020-03-208

OAAI

Hang Ling

个人简介

教育背景

工作经历

荣誉奖项

研究方向